wpengine
  • About Us
    • Who We Are
    • Our History
    • Mission & Values
    • Our Leadership
    • Why Choose Jost
  • Products
    • Ammonium
    • Calcium
    • Copper
    • Iron
    • Magnesium
    • Manganese
    • Potassium
    • Sodium
    • Strontium
    • Zinc
    • Ultra Pure Minerals (Low Heavy Metals)
    • Infant Pure (Low Chlorate Minerals)
    • Pharma Pure
    • JOSTCOTE® Microencapsulated Products
    • New Products
    • Custom Products
  • Our Expertise
    • cGMP Manufacturing
    • Quality
    • Research & Development
    • Customer Service
  • Markets
    • Nutritional
    • Pharmaceutical / Biotech
    • Specialty
  • Media
    • News
    • Events
    • Videos
    • Webinars
  • Technical Info
    • Documents
    • Links
  • Contact Us
    • Sales & Customer Service
    • Our Locations
  • Careers
Jost Chemical Co.
  • FAQ
  • Download Catalog
  • 314-428-4300
  • About Us
    • Who We Are
    • Our History
    • Mission & Values
    • Our Leadership
    • Why Choose Jost
  • Products
    • Ammonium
    • Calcium
    • Copper
    • Iron
    • Magnesium
    • Manganese
    • Potassium
    • Sodium
    • Strontium
    • Zinc
    • Ultra Pure Minerals (Low Heavy Metals)
    • Infant Pure (Low Chlorate Minerals)
    • Pharma Pure
    • JOSTCOTE® Microencapsulated Products
    • New Products
    • Custom Products
  • Our Expertise
    • cGMP Manufacturing
    • Quality
    • Research & Development
    • Customer Service
  • Markets
    • Nutritional
    • Pharmaceutical / Biotech
    • Specialty
  • Media
    • News
    • Events
    • Videos
    • Webinars
  • Technical Info
    • Documents
    • Links
  • Contact Us
    • Sales & Customer Service
    • Our Locations
  • Careers
Home › Related Articles › Osteoporosis treated with magnesium lactate.
Acta Universitatis Palackianae Olomucensis. 1991 Jan

Osteoporosis treated with magnesium lactate.

Abstract:

33 patients with senile, 18 patients with postmenopausal and 9 patients with medicamentous (corticosteroids) osteoporosis were treated with single therapy of Mg lactate (37 patients) and with the combined one of Mg lactate and Na fluoride (23 patients). They were evaluated in three periods of half a year, one year, two years. The better results were achieved with the single therapy than with the combined one and in the senile and postmenopausal osteoporosis than in the medicamentous one. Pain and restricted spine movement were influenced favourably. Kyphosis and x-ray findings were stabilized.

PMID 1837680  /  Steidl L, Ditmar R

Related Products
  • Magnesium Lactate Anhydrous Purified Granular – Product Code 2528
  • Magnesium Lactate Anhydrous Purified Powder – Product Code 2529
  • Magnesium Lactate Dihydrate EP Granular – Product Code 2531
  • Magnesium Lactate Dihydrate EP Low HM Granular – Product Code 2536
  • Magnesium Lactate Dihydrate EP Low HM Powder – Product Code 2533
  • Magnesium Lactate Dihydrate EP Powder – Product Code 2530
  • News
    • Company News
    • Product Development
    • Industry News
    • Awards
  • Events
  • Videos
  • Webinars
  • Documents

Learn about new Jost products and events.
subscribe

  • Who We Are
  • Products
  • Documents
  • News
  • Contact
  • Careers
  • Spanish
  • German
  • French

Follow Us

  • linkedin
  • facebook

Jost Chemical Co.
(The Americas and Asia)
8150 Lackland
St. Louis, MO 63114
Tel: +1 314 428 4300
Fax: +1 314 428 4366
customer.service@jostchemical.comcustomer.service@jostchemical.com

Jost Chemical Poland sp. z o.o
(Europe, Middle East and Africa)
ul. gen. Kazimierza Pułaskiego 7
64-000 Kościan, Poland
Tel: +48 65 322 69 00
Fax: +48 65 322 69 06
customer.service@jostchemical.comcustserv@jostchemical.com

Sitemap     Cookies     Terms of Use

Copyright © 1995–2022 Jost Chemical Co. All rights reserved.